2017-2021 US HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts
This DataPack presents the US test volume and sale forecasts for HIV-1/2/combo, HIV Ag, NAT, Western Blot and other confirmatory assays performed in the following market segments:
- Hospitals
- Commercial/Private Labs
- Blood Banks
- Public Health Labs
- Physician Offices
Major Companies Developing or Marketing AIDS Tests
USA: HIV or HIV1/2/Combo Test Volume and Sales Forecast by Market Segment
USA: HIV Ag Test Volume and Sales Forecast by Market Segment
USA: Western Blot/Other Confirmatory Tests Volume and Sales Forecast By Market Segment
USA: HIV NAT Blood Screening Test Volume and Diagnostics Sales
USA: AIDS Diagnostics Market by Major Supplier
USA: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
USA: HIV or HIV1/2/Combo Test Volume and Sales Forecast by Market Segment
USA: HIV Ag Test Volume and Sales Forecast by Market Segment
USA: Western Blot/Other Confirmatory Tests Volume and Sales Forecast By Market Segment
USA: HIV NAT Blood Screening Test Volume and Diagnostics Sales
USA: AIDS Diagnostics Market by Major Supplier
USA: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
More Publications
2015 US HIV/AIDS Diagnostic Testing Market: HIV 1/2, Combo, Ag, NAT, Western Blot - Supplier Shares, Country Segment Volume and Sales Forecasts
US$ 1,160.00
September 2015
-
2017-2021 France HIV/AIDS Diagnostics Market: Blood Banks, Commercial Labs, Hospitals--HIV 1/2, Combo, Ag, NAT, Western Blot----Supplier Shares, Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures
US$ 2,070.00
January 2017
250 pages
Germany HIV/AIDS Diagnostics Market: Blood Banks, Commercial Labs, Hospitals--HIV 1/2, Combo, Ag, NAT, Western Blot----Supplier Shares, Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures
US$ 1,840.00
June 2016
250 pages
